Athira Says Phase II Alzheimer’s Miss Will Inform Ongoing Phase III Study

 
• By Joseph Haas
  
Alzheimers_677117191_Atthapon-Raksthaput_1200.jpg
Athira faces a setback for its mechanism against Alzheimer's disease
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D